UNRESECTABLE NON-SMALL CELL LUNG-CANCER CHEMOTHERAPY WITH HIGH-DOSE CISPLATIN AND ETOPOSIDE

被引：10
|
作者：
SCAGLIOTTI, GV [1 ]
LODICO, D [1 ]
GOZZELINO, F [1 ]
BARDESSONO, F [1 ]
ALBERA, C [1 ]
GATTI, E [1 ]
PESCETTI, G [1 ]
机构：
[1] UNIV TURIN,INST INTERNAL MED,I-10124 TURIN,ITALY
来源：
ONCOLOGY | 1985年 / 42卷 / 04期
关键词：
D O I：
10.1159/000226035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：224 / 228
页数：5
相关论文
共 50 条
  • [31] PHARMACOKINETIC STUDY OF HIGH-DOSE ETOPOSIDE INFUSION IN PATIENTS WITH SMALL CELL LUNG-CANCER
    TARPEY, A
    GREEN, JA
    WARENIUS, HM
    BRITISH JOURNAL OF CANCER, 1985, 52 (03) : 462 - 462
  • [32] HIGH-DOSE ETOPOSIDE (VP-16) IN SMALL-CELL LUNG-CANCER
    GRECO, FA
    JOHNSON, DH
    HANDE, KR
    PORTER, LL
    HAINSWORTH, JD
    WOLFF, SN
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 42 - 44
  • [33] ETOPOSIDE V ETOPOSIDE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER - A FONICAP RANDOMIZED STUDY
    ROSSO, R
    ARDIZZONI, A
    SALVATI, F
    GALLOCURCIO, C
    RUBAGOTTI, A
    FUSCO, V
    BRUNETTI, I
    DEPALMA, M
    CRUCSIANI, AR
    PORTALONE, L
    AQUILINI, M
    TONACHELLA, R
    RINALDI, M
    SORESI, E
    SACCANI, F
    CIOFFI, R
    MONACO, M
    SCODITTI, S
    FOLCO, U
    RIMOLDI, R
    LOGROSCINO, C
    PEDICINI, T
    BOTTA, M
    FERRARA, G
    BELLI, M
    SEMINARS IN ONCOLOGY, 1988, 15 (06) : 49 - 51
  • [34] PROSPECTIVE RANDOMIZED COMPARISON OF HIGH-DOSE AND STANDARD-DOSE ETOPOSIDE AND CISPLATIN CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    IHDE, DC
    MULSHINE, JL
    KRAMER, BS
    STEINBERG, SM
    LINNOILA, RI
    GAZDAR, AF
    EDISON, M
    PHELPS, RM
    LESAR, M
    PHARES, JC
    GRAYSON, J
    MINNA, JD
    JOHNSON, BE
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) : 2022 - 2034
  • [35] ETOPOSIDE VERSUS ETOPOSIDE PLUS HIGH-DOSE CISPLATIN IN THE MANAGEMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE RANDOMIZED FONICAP TRIAL
    ROSSO, R
    SALVATI, F
    ARDIZZONI, A
    CURCIO, CG
    RUBAGOTTI, A
    BELLI, M
    CASTAGNETO, B
    FUSCO, V
    SASSI, M
    FERRARA, G
    PIZZA, A
    PEDICINI, T
    SORESI, E
    SCODITTI, S
    CIOFFI, R
    FOLCO, U
    MONACO, M
    MERLANO, M
    RIMOLDI, R
    TONACHELLA, R
    CRUCIANI, A
    COLANTUONI, G
    RINALDI, M
    PORTALONE, L
    BRUZZI, P
    SANTI, L
    CANCER, 1990, 66 (01) : 130 - 134
  • [36] COMBINATION CHEMOTHERAPY (HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE, MECHLORETHAMINE, AND PROCARBAZINE) IN NON-SMALL CELL LUNG-CANCER
    BHASIN, RR
    NOGEIRIE, CP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (02) : 106 - 107
  • [37] ETOPOSIDE AND SPLIT-DOSE CISPLATIN IN SMALL-CELL LUNG-CANCER
    WILKE, H
    ACHTERRATH, W
    SCHMOLL, HJ
    GUNZER, U
    PREUSSER, P
    LENAZ, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 572 - 578
  • [38] High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer
    Schiller, JH
    SEMINARS IN ONCOLOGY, 1996, 23 (04) : 78 - 82
  • [39] CISPLATIN AND CARBOPLATIN IN COMBINATION WITH ETOPOSIDE AS A TREATMENT FOR NON-SMALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EORTC LUNG-CANCER WORKING PARTY
    KLASTERSKY, J
    CANCER TREATMENT REVIEWS, 1988, 15 : 33 - 40
  • [40] CISPLATIN PLUS ETOPOSIDE IN SMALL CELL LUNG-CANCER
    LOEHRER, PJ
    EINHORN, LH
    GRECO, FA
    SEMINARS IN ONCOLOGY, 1988, 15 (03) : 2 - 8
12345